MoneyWorks4Me

Ajanta Pharma - Quaterly Results

02 May 2024 Evaluate
The revenue zoomed 9.10% to Rs. 9260.70 millions for the quarter ended March 2024 as compared to Rs. 8488.60 millions during the corresponding quarter last year.The company has announced a 38.80% increase in its profits to Rs . 1626.90  millions for the  quarter ended March 2024 compared to Rs. 1172.10 millions in the corresponding quarter in the previous year.Operating profit for the quarter ended March 2024 rose to 2608.30 millions as compared to 1812.80 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 9260.70 8488.60 9.10 39711.20 34112.70 16.41 39711.20 34112.70 16.41
Other Income 336.80 367.50 -8.35 1164.80 1327.50 -12.26 1164.80 1327.50 -12.26
PBIDT 2608.30 1812.80 43.88 12359.10 8320.30 48.54 12359.10 8320.30 48.54
Interest 14.20 12.10 17.36 68.00 52.30 30.02 68.00 52.30 30.02
PBDT 2594.10 1800.70 44.06 12291.10 8268.00 48.66 12291.10 8268.00 48.66
Depreciation 334.70 321.10 4.24 1321.60 1269.50 4.10 1321.60 1269.50 4.10
PBT 2259.40 1479.60 52.70 10969.50 6998.50 56.74 10969.50 6998.50 56.74
TAX 632.50 307.50 105.69 2897.10 1411.30 105.28 2897.10 1411.30 105.28
Deferred Tax 34.20 -84.50 -140.47 121.30 -29.30 -513.99 121.30 -29.30 -513.99
PAT 1626.90 1172.10 38.80 8072.40 5587.20 44.48 8072.40 5587.20 44.48
Equity 252.70 252.70 0.00 252.70 252.70 0.00 252.70 252.70 0.00
PBIDTM(%) 28.17 21.36 31.89 31.12 24.39 27.60 31.12 24.39 27.60
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..